Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BUSCLAB - A Double Blind Randomized Placebo-Controlled Trial Investigating the Effect of Intravenous Butylscopolamine Bromide to Prevent Slow Progress in Labor

NCT03961165 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03961165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BUSCLAB - A Double Blind Randomized Placebo-Controlled Trial Investigating the Effect of Intravenous Butylscopolamine Bromide to Prevent Slow Progress in Labor
Lead sponsor
Oslo University Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 25, 2019
Completion date
June 16, 2022
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labor (obstetrics)--complications, labor; prolonged, first stage